Lupus Nephritis Drug Voclosporin Shows Efficacy, Safety Over 3 Years
One study focused on patients with severe lupus nephritis, who are at greatest risk for kidney failure.
Diagnosis & Disease Information
RAAS Inhibitor Discontinuation After Hyperkalemia Tied to Adverse Outcomes
Discontinuation of RAAS inhibitors is often the first approach to manage hyperkalemia.
Vitamin D3 Does Not Improve Cardiovascular, Cancer Outcomes
The VITAL randomized clinical trial tested vitamin D and marine omega-3 fatty acid supplements in the primary prevention of cancer and cardiovascular disease.
Active Vitamin D Does Not Reduce Fracture Risk in SHPT
Active vitamin D does not appear to improve bone strength or reduce fracture risk beyond PTH suppression in patients on dialysis.
Etelcalcetide Use Fell After Change in Dialysis Payment Bundle
On January 1, 2021, calcimimetics such as etelcalcetide were no longer reimbursed using the Transitional Drug Add-On Payment Adjustment.
Methotrexate Added to Pegloticase for Gout Safe for Kidneys
Investigators report findings from the MIRROR RCT trial, which compared pegloticase plus methotrexate vs placebo for uncontrolled gout.
Prostate Cancer More Likely To Be Treated in Patients on Dialysis
New findings suggest active surveillance should be performed in this population and should not preclude transplant eligibility, according to investigators.
Kidney Function Declines More Slowly With SGLT2 Inhibitor
Treatment with an SGLT2 inhibitor may help patients with CKD or type 2 diabetes better preserve their kidney function.
AKI, AKD Are Common Complications of Radical Cystectomy
In a study, acute kidney injury and acute kidney disease developed in 51.4% and 37.5% of patients who underwent radical cystectomy for muscle-invasive bladder cancer.
Rapid Weight Loss May Be Risky in CKD
Study underscores the importance of maintaining or increasing lean body mass during weight loss.
- Loading...
Loading...
Next post in Kidney Week 2022
Loading... 
Loading...